Biogen (BIIB) Short-Term Debt issuances (2009 - 2011)

Biogen (BIIB) recorded quarterly Short-Term Debt issuances of -$7.5 million in Q3 2011, down 208.14% quarter-over-quarter from $7.0 million in Q2 2011, and down 2205.83% on a YoY basis from $356961.7 in Q3 2010.

Biogen (BIIB) Short-Term Debt issuances (2009 - 2011) Analysis & Trends

Biogen's Short-Term Debt issuances history runs 3 years deep, the most recent figure standing at -$7.5 million for Q3 2011.

  • In Q3 2011, Short-Term Debt issuances fell 2205.83% year-over-year to -$7.5 million; the TTM figure through Sep 2011 stood at $6.2 million (down 16.31% YoY), while the FY2010 annual figure was $11.8 million, down 4.02% from the prior year.
  • Short-Term Debt issuances was -$7.5 million for Q3 2011 at Biogen, down from $7.0 million in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $9.2 million in Q4 2010 to a low of -$7.5 million in Q3 2011.
  • Historically, Short-Term Debt issuances has averaged $1.9 million across 3 years, with a median of $1.4 million in 2009.
  • The sharpest annual moves came in 2010 and 2011: Short-Term Debt issuances soared 92.44% in 2010, then slumped 2205.83% in 2011.
  • A 3-year view of Short-Term Debt issuances shows it stood at $4.8 million in 2009, then jumped by 92.44% to $9.2 million in 2010, then plunged by 181.75% to -$7.5 million in 2011.
  • The last three Short-Term Debt issuances figures came in at -$7.5 million (Q3 2011), $7.0 million (Q2 2011), and -$2.5 million (Q1 2011), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn 1.61 Bn
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn 1.78 Bn
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn 12.44 Bn
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn -499.00 Mn
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn 1.06 Bn
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn -
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn -
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn -127.00 Mn
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn 321.00 Mn
10 Biogen 29.33 Bn 25.05 Bn 1.82 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2011 -7.52 Mn
Sep 30, 2011 -7.52 Mn
Jun 30, 2011 6.95 Mn
Jun 30, 2011 6.95 Mn
Mar 31, 2011 -2.47 Mn
Mar 31, 2011 -2.47 Mn
Dec 31, 2010 9.20 Mn
Dec 31, 2010 9.20 Mn
Sep 30, 2010 -326,000.00
Sep 30, 2010 -326,000.00
Jun 30, 2010 4.74 Mn
Jun 30, 2010 4.74 Mn
Mar 31, 2010 -1.83 Mn
Mar 31, 2010 -1.83 Mn
Dec 31, 2009 4.78 Mn
Dec 31, 2009 4.78 Mn
Sep 30, 2009 -28,000.00
Sep 30, 2009 -28,000.00
Jun 30, 2009 6.16 Mn
Jun 30, 2009 6.16 Mn